Lejárt a biztonsági időkorlát.
Ha az oldal űrlapot is tartalmaz, annak mentése csak érvényes bejelentkezéssel lehetséges.
A bejelentkezés érvényességének meghosszabbításához kérjük lépjen be!
Felhasználó név:
Jelszó:
 

MLDT HÍREK


Hírkategória: Általános
  • Alzheimer's disease therapeutics & biofluid tests: Current practice and future prospects c. IFCC webinárium 2021. október 28-án, 18:30 órakor
    2021.10.22. - MLDT - Hírkategória: Általános

    “Alzheimer’s disease therapeutics & biofluid tests: Current practice and future prospects”

    28th October 2021

     

    The webinar will last 90 minutes

    Register at: https://www.workcast.com/register?cpak=5390610616631173

     

    Time Zones: 9:30 AM Pacific Time, 6:30 PM European Time, 13:30 PM Argentina Time

    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone.
    To calculate this, you can use the time zone converter tool here

     

    This session will provide an overview of the rapidly evolving landscape of: (i) the use, reporting and interpretation of cerebrospinal fluid (CSF) Alzheimer’s disease biomarkers in clinical care, (ii) the development of peripheral (i.e.,blood-based) biomarkers and assays for Alzheimer’s disease, and (iii) the state of disease-modifying therapeutics for Alzheimer’s disease, including current and future uses of biomarkers related to therapeutics.

     

    The Webinar will consist of three talks (20 minutes each) and will be followed by the panel discussion - Registrants will be able to ask questions to the presenters.

     

    Chair: Dr. Robert Rissman (USA)

     

    Talk 1: A primer on Alzheimer’s neuropathology and current treatments

    Speaker: Dr. Haakon B. Nygaard (Canada)

     

    Talk 2: Clinical implementation of CSF biomarkers for Alzheimer’s disease

    Speaker: Dr. Mari DeMarco (Canada)

     

    Talk 3: Blood-based biomarkers of Alzheimer’s disease

    Speaker: Dr. Melissa Budelier (USA)

Vissza a hírekhez